X4 Pharmaceuticals Announces Key Enrollment Milestone Achievements in Ongoing Mavorixafor Clinical Trials and Reports Second Quarter Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/14/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to X4 Pharmaceuticals Announces Key Enrollment Milestone Achievements in Ongoing Mavorixafor Clinical Trials and Reports Second Quarter Financial Results
(NASDAQ: XFOR) Delayed: 4.00 +0.12 (3.09%)
Previous Close $3.88    52 Week High $ 
Open $3.93    52 Week Low $ 
Day High $4.02    P/E N/A 
Day Low $3.90    EPS $ 
Volume 501,549